Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) can cause side effects that range from mild to serious. More common side effects include headache and ...
Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is an inhaled medication used to treat chronic obstructive pulmonary disease (COPD) and asthma in adults. Common ...
The prescribed dosage for Breo Ellipta may depend on your individual treatment plan. Factors like your condition, medical history, age, and other treatments you take may affect your dosage of Breo ...
Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name inhaler prescribed for COPD and asthma. Trelegy Ellipta has interactions with some other drugs ...
RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., Oct. 30, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that BREO ELLIPTA, a ...
GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO® ELLIPTA® (fluticasone furoate/vilanterol [FF/VI]) ...
Chez les patients asthmatiques, il convient d'utiliser le dosage de Relvar Ellipta contenant la dose de furoate de fluticasone (FF) appropriée à la sévérité de leur maladie. Dans l'asthme, le furoate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results